Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catalina Medarde-Caballero

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Acta Ophthalmologica|April 24, 2012
A new fractioning process to decrease the price of ranibizumabMiguel González-Andrades, José Ignacio Muñoz-Ávila, Catalina Medarde-Caballero, et al.
Pharmacogenomics|April 1, 2015
FcGR genetic polymorphisms and the response to adalimumab in patients with rheumatoid arthritisCristina Lucía Dávila-Fajardo, Tahar van der Straaten, Rene Baak-Pablo, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Acta Ophthalmologica|April 24, 2012
A new fractioning process to decrease the price of ranibizumabMiguel González-Andrades, José Ignacio Muñoz-Ávila, Catalina Medarde-Caballero, et al.
Pharmacogenomics|April 1, 2015
FcGR genetic polymorphisms and the response to adalimumab in patients with rheumatoid arthritisCristina Lucía Dávila-Fajardo, Tahar van der Straaten, Rene Baak-Pablo, et al.
Pageof 1